ACS Omega
(Nov 2020)
Antidiabetic Effects of a Tripeptide That Decreases Abundance of Na+‑d‑glucose Cotransporter SGLT1 in the Brush-Border Membrane of the Small Intestine
- Christoph Otto,
- Alexandra Friedrich,
- Ivana Vrhovac Madunić,
- Christian Baumeier,
- Robert W. Schwenk,
- Dean Karaica,
- Christoph-Thomas Germer,
- Annette Schürmann,
- Ivan Sabolić,
- Hermann Koepsell
Affiliations
- Christoph Otto
- Department of General, Visceral, Transplantation, Vascular and Pediatric Surgery, University Hospital of Würzburg, Würzburg, Germany
- Alexandra Friedrich
- Institute of Anatomy and Cell Biology, University of Würzburg, Würzburg, Germany
- Ivana Vrhovac Madunić
- Molecular Toxicology Unit, Institute for Medical Research and Occupational Health, Zagreb, Croatia
- Christian Baumeier
- Department of Experimental Diabetology, German Institute of Human Nutrition, Potsdam-Rehbruecke, Germany
- Robert W. Schwenk
- Department of Experimental Diabetology, German Institute of Human Nutrition, Potsdam-Rehbruecke, Germany
- Dean Karaica
- Molecular Toxicology Unit, Institute for Medical Research and Occupational Health, Zagreb, Croatia
- Christoph-Thomas Germer
- Department of General, Visceral, Transplantation, Vascular and Pediatric Surgery, University Hospital of Würzburg, Würzburg, Germany
- Annette Schürmann
- Department of Experimental Diabetology, German Institute of Human Nutrition, Potsdam-Rehbruecke, Germany
- Ivan Sabolić
- Molecular Toxicology Unit, Institute for Medical Research and Occupational Health, Zagreb, Croatia
- Hermann Koepsell
- Institute of Anatomy and Cell Biology, University of Würzburg, Würzburg, Germany
- DOI
-
https://doi.org/10.1021/acsomega.0c03844
- Journal volume & issue
-
Vol. 5,
no. 45
pp.
29127
– 29139
WeChat QR code
